- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Mixed histology protective factor impacting overall survival and progression free survival in Neuroendocrine Carcinoma of Cervix: Study
Neuroendocrine carcinoma of the cervix (NECC) , a rare type of cervical cancer, has a poor prognosis and is more aggressive compared to more common types, with a 5-year survival rate ranging from 0% to 30%. Recent research paper focused on evaluating the prognostic factors and survival outcomes of patients who underwent surgery for high-grade neuroendocrine carcinoma of the cervix (NECC). The study was a multicenter retrospective analysis involving 98 patients with high-grade NECC at different stages. Patients were divided into pure and mixed histology groups, with 60 patients in the pure group and 38 in the mixed group. The study identified various prognostic factors affecting overall survival (OS) and progression-free survival (PFS) in surgically treated high-grade NECC.
Impact of Histology on Survival Outcomes
The findings revealed that mixed histology was a protective factor impacting OS and PFS, while factors like ovarian preservation, age over 45 years, tumor size over 4 cm, parity over 3, and perineural invasion were associated with negative survival outcomes. Kaplan–Meier survival curves showed significant differences in histologic type, chemotherapy, ovarian preservation, uterine invasion, and depth of stromal invasion, affecting OS and PFS.
Prognosis and Treatment Recommendations
Patients with mixed histologic types had a better prognosis, while those with high-risk factors should receive more attention in clinical practice. The study emphasized the importance of accurate pathologic diagnosis and the need for continued research in understanding and treating high-grade NECC. The results also suggested that patients with high-grade NECC may benefit from specific treatments like adjuvant EP chemotherapy and avoiding ovarian preservation.
Significance of Clinicopathologic Factors
The study highlighted the significance of clinicopathologic factors such as tumor size, staging, surgical margins, and uterine invasion in evaluating cervical cancer prognosis. Limitations of the study included a small sample size and the rarity of high-grade NECC, which necessitates further research with larger sample sizes and extended follow-up periods to strengthen the evidence. Overall, the research findings contribute to enhancing the understanding and management of high-grade NECC patients.
Key Points
1. The research evaluated prognostic factors and survival outcomes of patients who underwent surgery for high-grade neuroendocrine carcinoma of the cervix (NECC) through a multicenter retrospective analysis involving 98 patients at various stages, with 60 in the pure histology group and 38 in the mixed histology group.
2. Mixed histology was identified as a protective factor impacting overall survival (OS) and progression-free survival (PFS), while factors like ovarian preservation, age over 45 years, tumor size over 4 cm, parity over 3, and perineural invasion were associated with negative survival outcomes. Kaplan–Meier survival curves showed significant differences in histologic type, chemotherapy, ovarian preservation, uterine invasion, and depth of stromal invasion affecting OS and PFS.
3. Patients with mixed histologic types demonstrated a better prognosis, emphasizing the need for attention to high-risk factors in clinical practice. The study underscored the importance of accurate pathologic diagnosis and called for further research in understanding and treating high-grade NECC. Specific treatments like adjuvant EP chemotherapy were suggested, and avoiding ovarian preservation was recommended for patients with high-grade NECC.
4. Clinicopathologic factors such as tumor size, staging, surgical margins, and uterine invasion were deemed significant in evaluating cervical cancer prognosis. The study acknowledged limitations, including a small sample size and rarity of high-grade NECC, prompting the call for larger sample sizes and extended follow-up periods to strengthen the evidence and insight into managing high-grade NECC patients.
5. The research contributes to enhancing knowledge and management strategies for high-grade NECC patients, emphasizing the impact of histology, prognostic factors, and treatment recommendations on survival outcomes. Understanding the clinicopathologic factors affecting cervical cancer prognosis is crucial for improving patient care and outcomes.
6. Overall, the study provides valuable insights into prognostic factors, survival outcomes, and treatment considerations for high-grade NECC patients, highlighting the significance of histology, clinicopathologic factors, and the need for continued research to optimize the management of this rare and challenging cancer type.
Reference –
Lyu YH, Liu HX, Han X, Yuan P, Wang MY, He YY, Ge JL, Zou W, Jing R, Xin CS, Yang H, Chen BL, Chen GW, Li J. Clinicopathologic characteristics and prognostic factors of patients with surgically treated high-grade neuroendocrine carcinoma of the cervix: A multicenter retrospective study. Int J Gynaecol Obstet. 2024 Dec;167(3):1055-1065. doi: 10.1002/ijgo.15771. Epub 2024 Jul 19. PMID: 39031110.